Mid-Cap Tech and Healthcare Face Critical Tests: From Delisting Risks to Mega FinancingsGlobal Report·Jul 26 at 04:15 AMCYCU+495.85%BJDX+5.77%
Navigating Cross-Border Currents: Sector Divergence and Strategic Pivots in a Fragmented 2026 MarketGlobal Report·Jul 25 at 04:13 AMGNRC-1.68%TGTX+9.00%
Divergent Signals: Niche Equities Show Idiosyncratic Resilience Amid Macro UncertaintyGlobal Report·Jul 24 at 04:12 AMSDGR+1.52%TAL+13.31%
17:20 ETKuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firmprnewswire·Jul 21 at 04:21 PMTGTX+9.00%
Returns Matter: NUTX +214%, CORT +145%, GKOS +97% - Were These Biotech Stocks In Your Portfolio?rttnews·Jul 13 at 03:59 AMCORT+27.29%GKOS+4.24%
Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)Tip Ranks·Jul 7 at 05:55 AMTGTX+9.00%
TG Therapeutics: Buy Rating Reaffirmed as Briumvi Schizophrenia Trial Adds Upside Optionality; $70 Price Target UnchangedTip Ranks·Jul 6 at 10:25 AMTGTX+9.00%
TG Therapeutics initiates Phase 2 trial of Briumvi in treatment-resistant schizophrenia patientsPUBT·Jul 6 at 06:31 AMTGTX+9.00%
TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia | TGTX Stock NewsStockTitan·Jul 5 at 10:30 PMTGTX+9.00%
10 Health Care Stocks With Whale Alerts In Today’s Sessionbenzinga_article·Jul 1 at 12:35 PMCRSP+1.68%PURR+5.53%
TG Therapeutics Stock Rises Thursday: What's Driving The Gains?benzinga_article·Jun 18 at 02:29 PMTGTX+9.00%
Top 3 Health Care Stocks That May Collapse This Quarterbenzinga_article·Jun 15 at 07:51 AMAMRX-3.14%CAH-0.89%
